MEDIPAL HOLDINGS CORP.MEDIPAL HOLDINGS CORP.MEDIPAL HOLDINGS CORP.

MEDIPAL HOLDINGS CORP.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.83 B‬EUR
‪253.96 M‬EUR
‪21.79 B‬EUR
‪169.73 M‬
Beta (1Y)
0.43
Employees (FY)
‪13.07 K‬
Change (1Y)
+280 +2.19%
Revenue / Employee (1Y)
‪1.80 M‬EUR
Net income / Employee (1Y)
‪20.96 K‬EUR

About MEDIPAL HOLDINGS CORP


CEO
Shuichi Watanabe
Headquarters
Tokyo
Founded
1898
ISIN
JP3268950007
FIGI
BBG00W5FDLZ1
Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. Its operations are carried out through the following segments: Prescription Pharmaceutical Wholesale Business; Cosmetics, Daily Necessities, and Over-The-Counter (OTC) Pharmaceutical Wholesale Business; and Animal Health Products Wholesale Business. The Prescription Pharmaceutical Wholesale Business segment conducts wholesale business for hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and OTC Pharmaceutical Wholesale Business segment deals with wholesale business for drugstores, home centers, convenience stores, and supermarkets. The Animal Health Products Wholesale Business segment handles wholesale business for animal hospitals, farms, agricultural cooperatives, and processed food manufacturers. The company was founded on October 8, 1898 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 59Z is 15.4 EUR — it has increased by 1.32% in the past 24 hours. Watch MEDIPAL HOLDINGS CORP. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MEDIPAL HOLDINGS CORP. stocks are traded under the ticker 59Z.
59Z stock has risen by 2.68% compared to the previous week, the month change is a 8.51% rise, over the last year MEDIPAL HOLDINGS CORP. has showed a 5.48% increase.
We've gathered analysts' opinions on MEDIPAL HOLDINGS CORP. future price: according to them, 59Z price has a max estimate of 16.92 EUR and a min estimate of 14.02 EUR. Watch 59Z chart and read a more detailed MEDIPAL HOLDINGS CORP. stock forecast: see what analysts think of MEDIPAL HOLDINGS CORP. and suggest that you do with its stocks.
59Z reached its all-time high on Mar 29, 2021 with the price of 18.0 EUR, and its all-time low was 11.5 EUR and was reached on Nov 4, 2022. View more price dynamics on 59Z chart.
See other stocks reaching their highest and lowest prices.
59Z stock is 0.65% volatile and has beta coefficient of 0.43. Track MEDIPAL HOLDINGS CORP. stock price on the chart and check out the list of the most volatile stocks — is MEDIPAL HOLDINGS CORP. there?
Today MEDIPAL HOLDINGS CORP. has the market capitalization of ‪3.22 B‬, it has decreased by −0.14% over the last week.
Yes, you can track MEDIPAL HOLDINGS CORP. financials in yearly and quarterly reports right on TradingView.
MEDIPAL HOLDINGS CORP. is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
59Z earnings for the last quarter are 0.38 EUR per share, whereas the estimation was 0.33 EUR resulting in a 13.94% surprise. The estimated earnings for the next quarter are 0.24 EUR per share. See more details about MEDIPAL HOLDINGS CORP. earnings.
MEDIPAL HOLDINGS CORP. revenue for the last quarter amounts to ‪5.72 B‬ EUR, despite the estimated figure of ‪5.70 B‬ EUR. In the next quarter, revenue is expected to reach ‪6.12 B‬ EUR.
59Z net income for the last quarter is ‪79.47 M‬ EUR, while the quarter before that showed ‪52.25 M‬ EUR of net income which accounts for 52.10% change. Track more MEDIPAL HOLDINGS CORP. financial stats to get the full picture.
MEDIPAL HOLDINGS CORP. dividend yield was 2.59% in 2023, and payout ratio reached 30.64%. The year before the numbers were 2.55% and 24.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 3, 2024, the company has ‪13.07 K‬ employees. See our rating of the largest employees — is MEDIPAL HOLDINGS CORP. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIPAL HOLDINGS CORP. EBITDA is ‪465.24 M‬ EUR, and current EBITDA margin is 1.84%. See more stats in MEDIPAL HOLDINGS CORP. financial statements.
Like other stocks, 59Z shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIPAL HOLDINGS CORP. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIPAL HOLDINGS CORP. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIPAL HOLDINGS CORP. stock shows the strong buy signal. See more of MEDIPAL HOLDINGS CORP. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.